MAINTENANCE TREATMENT WITH PROTON PUMP INHIBITORS AFTER HEALING OF REFLUX ESOPHAGITIS IN PAEDIATRIC PATIENTS: A SYSTEMATIC REVIEW

(1) AstraZeneca LP, Wilmington, United States

(2) AstraZeneca R&D, Mölndal, Sweden

(3) Research Evaluation Unit, Oxford PharmaGenesis Ltd, Oxford, United Kingdom



This item was part of the PAEDIATRIC GASTROENTEROLOGY AND HEPATOLOGY II session at Gastro 2009 UEGW/WCOG London (17th UEGW)